Therapix Biosciences

1 stories about Therapix Biosciences
קנאביס קנביס רפואי מריחואנה יצוא

Canada's FSD Pharma to Acquire Israeli Therapix Biosciences for $48 Million in Stock

23.10.18|Lilach Baumer
Clinical-stage Therapix Biosciences develops cannabinoid-based drugs for the treatment of neurological conditions, pain management, and infectious diseases